Get the app!
Back to Trades

Kumar Neil

Chief Executive Officer, DirectorCIK: 0001742485
Total Volume
$40.6M
Purchases
$0
Sales
$34.4M
Companies
2

Companies Traded

BridgeBio Pharma, Inc. (BBIO)BridgeBio Oncology Therapeutics, Inc. (BBOT)

Trading History (12 filings)

BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Jan 12, 2026
Sell
$6.0M
14 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Dec 16, 2025
Sell
$2.2M
2 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Dec 8, 2025
Sell
$5.9M
10 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Nov 24, 2025
Sell
$1.7M
3 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Nov 18, 2025
Other
$0
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Nov 10, 2025
Sell
$5.0M
12 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Oct 10, 2025
Sell
$4.4M
6 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilChief Executive Officer, Director
Filed Sep 8, 2025
Sell
$4.2M
10 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilInsider
Filed Aug 22, 2025
Sell
$1.3M
2 sales
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilInsider
Filed Aug 19, 2025
Other
$0
View DetailsSEC Filing
BridgeBio Oncology Therapeutics, Inc.(BBOT)
Kumar NeilInsider
Filed Aug 18, 2025
Other
$0
View DetailsSEC Filing
BridgeBio Pharma, Inc.(BBIO)
Kumar NeilInsider
Filed Aug 11, 2025
Sell
$3.7M
8 sales
View DetailsSEC Filing